Gainers

• AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session. The company's market cap stands at $146.1 million. As per the press release, Q2 earnings came out yesterday.
• Embecta (NASDAQ:EMBC) stock moved upwards by 32.42% to $4.63. The market value of their outstanding shares is at $207.2 million. As per the news, the Q3 earnings report came out today.
• Starling Oncology (NASDAQ:STLN) shares rose 32.06% to $6.59. The market value of their outstanding shares is at $498.9 million.
• Doximity (NYSE:DOCS) shares moved upwards by 31.65% to $27.2. The company's market cap stands at $3.7 billion. The company's, Q1 earnings came out yesterday.
• Senseonics Holdings (NASDAQ:SENS) stock rose 24.85% to $6.43. The market value of their outstanding shares is at $268.8 million. The company's, Q2 earnings came out yesterday.
• OmniAb (NASDAQ:OABI) shares moved upwards by 22.37% to $2.74. The company's market cap stands at $324.7 million. The company's, Q2 earnings came out yesterday.

Losers

• CVRx (NASDAQ:CVRX) stock declined by 57.8% to $2.5 during Friday's regular session. The company's market cap stands at $157.6 million. The company's, Q2 earnings came out yesterday.
• Organogenesis Holdings (NASDAQ:ORGO) stock decreased by 29.88% to $1.69. The market value of their outstanding shares is at $310.1 million. As per the news, the Q2 earnings report came out yesterday.
• BioVie (NASDAQ:BIVI) stock decreased by 25.12% to $1.01. The company's market cap stands at $10.1 million.
• Health Catalyst (NASDAQ:HCAT) stock declined by 24.9% to $1.74. The company's market cap stands at $170.6 million. The company's, Q2 earnings came out yesterday.
• QuidelOrtho (NASDAQ:QDEL) shares fell 23.04% to $12.56. The company's market cap stands at $1.1 billion. As per the press release, Q2 earnings came out yesterday.
• Autonomix Medical (NASDAQ:AMIX) shares fell 20.34% to $9.7. The company's market cap stands at $6.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.